| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 11/16/2010 | CA2389165C Substituted indoles for modulating nfkb activity |
| 11/16/2010 | CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions |
| 11/16/2010 | CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition |
| 11/11/2010 | WO2010129917A2 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | WO2010129864A2 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | WO2010129712A1 15-pgdh in colon cancer |
| 11/11/2010 | WO2010129242A2 Treatment of osteoarthritis pain |
| 11/11/2010 | WO2010128802A2 Composition comprising snowberry extract |
| 11/11/2010 | WO2010128663A1 Interleukin-2 production inhibitor |
| 11/11/2010 | WO2010128401A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| 11/11/2010 | WO2010127856A1 Substituted phenyllureas and phenylamides as vanilloid receptor ligands |
| 11/11/2010 | WO2010127704A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity |
| 11/11/2010 | WO2010127452A1 5-oxo-ete receptor antagonist compounds |
| 11/11/2010 | WO2010127440A1 Substituted aromatic compounds and pharmaceutical uses thereof |
| 11/11/2010 | WO2010127439A1 Ammo acid derivatives for the treatment of neuropathic pain |
| 11/11/2010 | WO2010093436A3 Toll-like receptor modulators and treatment of diseases |
| 11/11/2010 | WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors |
| 11/11/2010 | WO2010080712A3 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders |
| 11/11/2010 | WO2010042886A3 Pyrones for the treatment of metabolic disorders |
| 11/11/2010 | WO2010032269A3 Anti-inflammatory activity of the iridoid glycosides |
| 11/11/2010 | WO2010001179A3 Calcium ion channel modulators & uses thereof |
| 11/11/2010 | US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 11/11/2010 | US20100286276 Substituted 1,3-Diphenylpropane Derivatives, Preparations and Uses Thereof |
| 11/11/2010 | US20100286275 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| 11/11/2010 | US20100286269 Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents |
| 11/11/2010 | US20100286266 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 11/11/2010 | US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 11/11/2010 | US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 11/11/2010 | US20100286233 Peripheral and neural inflammatory crosstalk |
| 11/11/2010 | US20100286222 Use of inhibitors of soluble epoxide hydrolase to synergize activity of cox and 5-lox inhibitors |
| 11/11/2010 | US20100286216 Composition having a high osmotic activity and exhibiting antimicrobial, anti-inflammatory, and regenerative effects |
| 11/11/2010 | US20100286215 Bis-aromatic compounds useful in the treatment of inflammation |
| 11/11/2010 | US20100286210 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
| 11/11/2010 | US20100286208 Novel polymorph of esomeprazole potassium and process for its preparation |
| 11/11/2010 | US20100286207 Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same |
| 11/11/2010 | US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide |
| 11/11/2010 | US20100286202 New Compounds |
| 11/11/2010 | US20100286197 Carboxamide Derivatives As Therapeutic Agents |
| 11/11/2010 | US20100286193 Novel Azabicyclo[3.2.1]Oct-2-Ene Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 11/11/2010 | US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators |
| 11/11/2010 | US20100286190 Certain substituted ureas, as modulators of kinase activity |
| 11/11/2010 | US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor |
| 11/11/2010 | US20100286149 Novel benzamide derivatives useful as potassium channel modulators |
| 11/11/2010 | US20100286137 Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds |
| 11/11/2010 | US20100286136 Dihydronaphthyridinyl and related compounds for use in treating ophthalmological disorders |
| 11/11/2010 | US20100286134 Novel phenoxazin-3-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 11/11/2010 | US20100286128 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine-receptor ligands |
| 11/11/2010 | US20100286126 Organic Compounds |
| 11/11/2010 | US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 11/11/2010 | US20100286109 Amide derivatives as positive allosteric modulators and methods of use thereof |
| 11/11/2010 | US20100286108 Stabilized Steroid Composition and Method for its Preparation |
| 11/11/2010 | US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses |
| 11/11/2010 | US20100286086 Composition for the treatment of osteoarthritis |
| 11/11/2010 | US20100286080 Aqueous composition comprising chitosan and an acidic drug |
| 11/11/2010 | US20100286079 Composition comprising covalent conjugates of chitosan and an acidic drug and parenteral administration |
| 11/11/2010 | US20100286073 Compounds and methods for pharmaceutical use |
| 11/11/2010 | US20100286072 Retro-inverso peptides derived from interleukin-6 |
| 11/11/2010 | US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions |
| 11/11/2010 | US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| 11/11/2010 | US20100286031 Antibiotic Formulations, Unit Doses, Kits and Methods |
| 11/11/2010 | US20100286029 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286028 Use of a peptide as a therapeutic agent |
| 11/11/2010 | US20100286026 Novel protein |
| 11/11/2010 | US20100286020 milk protein composition and use thereof |
| 11/11/2010 | US20100285448 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 11/11/2010 | US20100285159 Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals |
| 11/11/2010 | US20100285154 Use of lignan compounds for treating or preventing inflammatory disease |
| 11/11/2010 | US20100285129 Novel agent for salting out active principles in dressings containing at least one of fatty substance |
| 11/11/2010 | US20100285124 Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological |
| 11/11/2010 | US20100285116 Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells |
| 11/11/2010 | US20100285075 Novel Hemioxalate Salt of Eletriptan |
| 11/11/2010 | US20100285064 Adjuvant composition for vaccine |
| 11/11/2010 | US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same |
| 11/11/2010 | US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 |
| 11/11/2010 | US20100285034 Method |
| 11/11/2010 | US20100285020 Leukemic cell cns infiltration controlled by notch-induced chemotaxis |
| 11/11/2010 | US20100285019 Anti-IL-17F Antibodies and Methods of Use Thereof |
| 11/11/2010 | US20100285015 Targeting recombinant therapeutics to circulating red blood cells |
| 11/11/2010 | US20100285004 Anti-CD38 human antibodies and uses thereof |
| 11/11/2010 | US20100285002 Treatment or prevention of inflammation by targeting cyclin d1 |
| 11/11/2010 | US20100284989 15-pgdh in colon cancer |
| 11/11/2010 | US20100284946 Compressed Chewing Gum Comprising Sterol |
| 11/11/2010 | US20100284945 Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy |
| 11/11/2010 | US20100284938 Penetrating pharmaceutical foam |
| 11/11/2010 | US20100284913 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | CA2799157A1 Ammo acid derivatives for the treatment of neuropathic pain |
| 11/11/2010 | CA2761018A1 Substituted aromatic compounds and pharmaceutical uses thereof |
| 11/11/2010 | CA2760946A1 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | CA2760890A1 Anti-cd100 antibodies and methods for using the same |
| 11/11/2010 | CA2760877A1 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| 11/11/2010 | CA2759951A1 Substituted phenylureas and phenylamides as vanilloid receptor ligands |
| 11/11/2010 | CA2756689A1 Treatment of osteoarthritis pain |
| 11/10/2010 | EP2248830A1 Use of antagonist anti-CD40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection |
| 11/10/2010 | EP2248811A1 2-oxochromene derivative |
| 11/10/2010 | EP2247597A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof |
| 11/10/2010 | EP2247595A1 Pyrrolopyrazine kinase inhibitors |
| 11/10/2010 | EP2247593A1 Pyrrolopyrazine kinase inhibitors |
| 11/10/2010 | EP2247592A1 Pyrrolopyrazine kinase inhibitors |
| 11/10/2010 | EP2247299A1 Molecular targets for treatment of inflammation |